Therapeutic challenges in renal cell carcinoma.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

1. Comprehensive Analysis of Genomic and Phenomic Data Reveals Context-Dependent Function of A20 (Cancers · 2026
   Article
2. Integrated single-cell and bulk characterization of branched chain amino acid metabolism-related key gene BCAT1 and association with prognosis and immunogenicity of clear cell renal cell carcinoma.Aging · 2024
   Article
3. Integrated analyses reveal the prognostic, immunological features and mechanisms of cuproptosis critical mediator gene FDX1 in KIRC.Genes and immunity · 2023
   Article
4. Predicting prognosis, immunotherapy and distinguishing cold and hot tumors in clear cell renal cell carcinoma based on anoikis-related lncRNAs.Frontiers in immunology · 2023
   Article
5. Current applications of nanomaterials in urinary system tumors.Frontiers in bioengineering and biotechnology · 2023
   Review
6. [Expression and significance of fibroblast growth factor receptor 2 in clear cell renal cell carcinoma].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2022
   Article
7. Renal Cell Carcinoma: A Complex Therapeutic Challenge in the Elderly.Cureus · 2022
   Review
8. Neferine increases sensitivities to multiple anticancer drugs via downregulation of Bcl-2 expression in renal cancer cells.Genes & genomics · 2022
   Article
9. Potassium channel-related genes are a novel prognostic signature for the tumor microenvironment of renal clear cell carcinoma.Frontiers in oncology · 2022
   Article
10. Spatial Distribution of Private Gene Mutations in Clear Cell Renal Cell Carcinoma.Cancers · 2021
    Article
11. Pyroptosis Regulators and Tumor Microenvironment Infiltration Characterization in Clear Cell Renal Cell Carcinoma.Frontiers in oncology · 2021
    Article
12. Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial.Journal for immunotherapy of cancer · 2019
    Article
13. MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential.Nature reviews. Urology · 2019
    Review
14. Genetic alterations in Japanese extrahepatic biliary tract cancer.Oncology letters · 2017
    Article
15. The therapeutic potential of HIF-2 antagonism in renal cell carcinoma.Translational andrology and urology · 2017
    Article
16. Expression and significance of B7-H3 and Tie-2 in the tumor vasculature of clear cell renal carcinoma.OncoTargets and therapy · 2017
    Article
17. Eupatilin induces human renal cancer cell apoptosis via ROS-mediated MAPK and PI3K/AKT signaling pathways.Oncology letters · 2016
    Article
18. Renal Cancer in the Elderly.Current urology reports · 2016
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as